Publications

2020

303.
Benor G., Fuks G., Chin S. et al. (2020) Molecular Oncology.  Abstract [All authors]
302.
Benor G., Fuks G., Chin S. et al. (2020) BioRxiv.  Abstract [All authors]

2019

301.
Oren M. (2019) Journal of Molecular Cell Biology. 11, 7, p. 539-543  Abstract
300.
Shreberk-Shaked M. & Oren M. (2019) Molecular Oncology. 13, 6, p. 1335-1341  Abstract
299.
Hooda J., Novak M., Salomon M. P. et al. (2019) Cancer Research. 79, 4, p. 760-772  Abstract [All authors]

2018

298.
Furth N., Pateras I. S., Rotkopf R. et al. (2018) Life science alliance. 1, 5, 201800171.  Abstract [All authors]
297.
Minzel W., Venkatachalam A., Fink A. et al. (2018) Cell. 175, 1, p. 171-+  Abstract [All authors]
296.
Kotler E., Segal E. & Oren M. (2018) Molecular & cellular oncology. 5, 6, 1511207.  Abstract
295.
Kotler E., Shani O., Goldfeld G. et al. (2018) Molecular Cell. 71, 1, p. 178-190.e8  Abstract [All authors]
294.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
293.
, Jethwa A., Slabicki M. et al. (2018) Blood. 131, 25, p. 2789-2802  Abstract [All authors]
292.
Ghannam-Shahbari D., Jacob E., Kakun R. R. et al. (2018) Oncogene. 37, 17, p. 2213-2224  Abstract [All authors]
291.
Solomon H., Dinowitz N., Pateras I. S. et al. (2018) Oncogene. 37, 12, p. 1669-1684  Abstract [All authors]
290.
, Galluzzi L., Vitale I. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract [All authors]

2017

289.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 12681–12699  Abstract [All authors]
288.
Aylon Y. & Oren M. (2017) Cancer Cell. 32, 4, p. 397-399  Abstract
287.
Spolverini A., Fuchs G., Bublik D. R. & Oren M. (2017) Oncogene. 36, 42, p. 5819-5828  Abstract
286.
Tovy A., Spiro A., McCarthy R. et al. (2017) GENES & DEVELOPMENT. 31, 10, p. 959-972  Abstract [All authors]
285.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
284.
Bublik D. R., Bursac S., Sheffer M. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505  Abstract [All authors]

2016

283.
p53 mutations promote proteasomal activity
Oren M. & Kotler E. (2016) Nature Cell Biology. 18, 8, p. 833-835  Abstract
282.
Stock K., Estrada M. F., Vidic S. et al. (2016) Scientific Reports. 6, 28951.  Abstract [All authors]
281.
Aylon Y. & Oren M. (2016) Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-55  Abstract
280.
Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016) Seminars in Cancer Biology. 37-38, p. 36-50  Abstract
279.
Oren M., Tal P. & Rotter V. (2016) AGING-US. 8, 6, p. 1159-1160  Abstract
278.
Yaeger R., Shah M. A., Miller V. A. et al. (2016) Gastroenterology. 151, 2, p. 278-287.e6  Abstract [All authors]
277.
Aylon Y., Gershoni A., Rotkopf R. et al. (2016) GENES & DEVELOPMENT. 30, 7, p. 786-97  Abstract [All authors]
276.
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016) Oncotarget. 7, 11, p. 11817-11837  Abstract
275.
Tarcic O., Pateras I. S., Cooks T. et al. (2016) Cell Reports. 14, 6, p. 1462-1476  Abstract [All authors]
274.
Hoffman Y., Bublik D. R., Ugalde A. P., Elkon R., Biniashvili T., Agami R., Oren M. & Pilpel Y. (2016) PLoS Genetics. p. 260-262  Abstract

2015

273.
Harel S., Ben-Moshe N., Aylon Y. et al. (2015) Cell Death and Differentiation. 22, p. 1328-1340  Abstract [All authors]
272.
Pribluda A., Elyada E., Wiener Z. et al. (2015) Cancer Cell. 27, 6, p. 877-878  Abstract [All authors]
271.
Fuchs G., Voichek Y., Rabani M., Benjamin S., Gilad S., Amit I. & Oren M. (2015) Nature Protocols. 10, 4, p. 605-618  Abstract
270.
Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015) Cell Death and Differentiation. 22, 11, p. 1764-1774  Abstract
269.
Oren M. & Arundkar S. C. (2015) Leukemia. 29, 10, p. 2015-2023  Abstract
268.
Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015) Genes and Development. 29, p. 2325-2330  Abstract

2014

267.
Lasry A., Aran D., Zinger A. et al. (2014) Cytokine. 70, 1, p. 22-22  Abstract [All authors]
266.
Fuchs G., Hollander D., Voichek Y., Ast G. & Oren M. (2014) Genome Research. 24, 10, p. 1572-1583  Abstract
265.
Cooks T., Harris C. & Oren M. (2014) Carcinogenesis. 35, 8, p. 1680-1690  Abstract
264.
Fuchs G. & Oren M. (2014) Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms. 1839, 8, p. 694-701  Abstract
263.
Golomb L., Volarevic S. & Oren M. (2014) FEBS Letters. 588, 16, p. 2571-2579  Abstract
262.
Weilbacher A., Gutekunst M., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2014) Cell Death & Disease. 5, e1318.  Abstract
261.
Hoffman Y., Pilpel Y. & Oren M. (2014) Journal of Molecular Cell Biology. 6, 3, p. 192-197  Abstract
260.
Aylon Y., Sarver A., Tovy A., Ainbinder E. & Oren M. (2014) Cell Death and Differentiation. 21, 4, p. 624-633  Abstract
259.
Pathways and therapeutic targets in melanoma
Shtivelman E., Davies M. A., Hwu P., Yang J., Lotem M., Oren M., Flaherty K. T. & Fisher D. E. (2014) Oncotarget. 5, 7, p. 1701-1752  Abstract
258.
Hoffman Y., Bublik D. R., Pilpel Y. & Oren M. (2014) Cell Death and Differentiation. 21, 2, p. 302-309  Abstract
257.
Fuchs G., Voichek Y., Benjamin S., Gilad S., Amit I. & Oren M. (2014) GENOME BIOLOGY. 15, 5, R69.  Abstract
256.
Weingarten-Gabbay S., Khan D., Liberman N., Yoffe Y., Bialik S., Das S., Oren M. & Kimchi A. (2014) Oncogene. 33, 5, p. 611-618  Abstract

2013

255.
Golomb L. & Oren M. (2013) Cell Death and Differentiation. 20, 11, p. 1442-1443  Abstract
254.
Fausti F., Di Agostino A. S., Cioce M. et al. (2013) Cell Death and Differentiation. 20, 11, p. 1498-1509  Abstract [All authors]
253.
Suzuki H., Yabuta N., Okada N., Torigata K., Aylon Y., Oren M. & Nojima H. (2013) Journal of Cell Science. 126, 19, p. 4358-4368  Abstract
252.
Pribluda A., Elyada E., Wiener Z. et al. (2013) Cancer Cell. 24, 2, p. 242-256  Abstract [All authors]
251.
Shema E., Nikolov M., Haj-Yahya M. et al. (2013) Cell Reports. 4, 3, p. 601-608  Abstract [All authors]
250.
Cooks T., Pateras I. S., Tarcic O. et al. (2013) Cancer Cell. 23, 5, p. 634-646  Abstract [All authors]
249.
Hoffman Y., Dahary D., Bublik D. R., Oren M. & Pilpel Y. (2013) Bioinformatics. 29, 7, p. 894-902  Abstract
248.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013)  Abstract
247.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Bedke J., Kruck S., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013) Cancer Research. 73, 5, p. 1460-1469  Abstract

2012

246.
Bursac S., Brdovcak M. C., Pfannkuchen M. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America. 109, 50, p. 20467-20472  Abstract [All authors]
245.
Hornung G., Bar-Ziv R., Rosin D., Tokuriki N., Tawfik D., Oren M. & Barkai N. (2012) Genome Research. 22, 12, p. 2409-2417  Abstract
244.
Schmid J. O., Dong M., Haubeiss S. et al. (2012) Cancer Research. 72, 22, p. 5824-5832  Abstract [All authors]
243.
Fuchs G., Shema E., Vesterman R. et al. (2012) Molecular Cell. 46, 5, p. 662-673  Abstract [All authors]
242.
Hornung G., Oren M. & Barkai N. (2012) Molecular Cell. 46, 3, p. 362-368  Abstract
241.
Bublik D. R. & Oren M. (2012) EMBO Reports. 13, 4, p. 282-283  Abstract
240.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
239.
Haj-Yahya M., Eltarteer N., Ohayon S., Shema E., Kotler E., Oren M. & Brik A. (2012) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 51, 46, p. 11535-11539  Abstract
238.
Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K. & Oren M. (2012) Cell Death and Differentiation. 19, 1, p. 180-183  Abstract
237.
Golomb L., Bublik D. R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S. & Oren M. (2012) Molecular Cell. 45, 2, p. 222-232  Abstract

2011

236.
Golomb L. & Oren M. (2011) Cancer Cell. 20, 3, p. 283-284  Abstract
235.
Furth N. & Oren M. (2011) Cell Cycle. 10, 18, p. 3054-3055  Abstract
234.
Shiloh Y., Shema E., Moyal L. & Oren M. (2011) FEBS Letters. 585, 18, p. 2795-2802  Abstract
233.
Aylon Y. & Oren M. (2011) Molecular Oncology. 5, 4, p. 315-323  Abstract
232.
Tarocchi M., Hannivoort R., Hoshida Y. et al. (2011) Hepatology. 54, 2, p. 522-531  Abstract [All authors]
231.
Shema E., Oren M. & Minsky N. (2011) Methods. 54, 3, p. 326-330  Abstract
230.
Dell'Orso S., Fontemaggi G., Stambolsky P. et al. (2011) Omics-A Journal Of Integrative Biology. 15, 5, p. 305-312  Abstract [All authors]
229.
Shema E., Kim J., Roeder R. G. & Oren M. (2011) Molecular Cell. 42, 4, p. 477-488  Abstract
228.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
227.
Gutekunst M., Oren M., Weilbacher A., Dengler M. A., Markwardt C., Thomale J., Aulitzky W. E. & van der Kuip d. K. H. (2011) PLoS One. 6, 4,  Abstract
226.
Elyada E., Pribluda A., Goldstein R. E. et al. (2011) Nature. 470, 7334, p. 409-U208  Abstract [All authors]
225.
Aylon Y. & Oren M. (2011) Current opinion in genetics & development. 21, 1, p. 86-92  Abstract
224.
Goldstein I., Marcel V., Olivier M., Oren M., Rotter V. & Hainaut P. (2011) Cancer Gene Therapy. 18, 1, p. 2-11  Abstract
223.
Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M. & Nojima H. (2011) Journal of Cell Science. 124, 1, p. 57-67  Abstract

2010

222.
Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R. N., Neeman M. & Oren M. (2010) Cancer Research. 70, 23, p. 9650-9658  Abstract
221.
Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X. & Oren M. (2010) GENES & DEVELOPMENT. 24, 21, p. 2420-2429  Abstract
220.
Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z. & Oren M. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 43, p. 18511-18516  Abstract
219.
Nili E. L., Field Y., Lubling Y., Widom J., Oren M. & Segal E. (2010) Genome Research. 20, 10, p. 1361-1368  Abstract
218.
Shalgi R., Pilpel Y. & Oren M. (2010) Trends in Genetics. 26, 6, p. 253-259  Abstract
217.
Schilling T., Kairat A., Melino G., Krammer P. H., Stremmel W., Oren M. & Mueller M. (2010) Biochemical and Biophysical Research Communications. 394, 3, p. 817-823  Abstract
216.
NF kappa B and p53: A life and death affair
Oren M. & Cooks T. (2010) Cell Cycle. 9, 6, p. 1027-1027  Abstract
215.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 3, p. 273-285  Abstract [All authors]
214.
Bar J., Moskovits N. & Oren M. (2010) SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 21, 1, p. 47-54  Abstract
213.
Christoffersen N. R., Shalgi R., Frankel L. B. et al. (2010) Cell Death and Differentiation. 17, 2, p. 236-245  Abstract [All authors]
212.
Oren M. & Rotter V. (2010) Cold Spring Harbor perspectives in biology. 2, 2,  Abstract

2009

211.
Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H. & Oren M. (2009) Oncogene. 28, 50, p. 4469-4479  Abstract
210.
Skorta I., Oren M., Markwardt C., Gutekunst M., Aulitzky W. E. & van der Kuip d. K. H. (2009) Cancer Research. 69, 24, p. 9337-9345  Abstract
209.
Lavelin I., Beer A., Kam Z., Boner V., Oren M., Navon A. & Geiger B. (2009) PLoS One. 4, 12,  Abstract
208.
Levine A. J. & Oren M. (2009) Nature Reviews Cancer. 9, 10, p. 749-758  Abstract
207.
Schilling T., Schleithoff E. S., Kairat A., Melino G., Stremmel W., Oren M., Krammer P. H. & Mueller M. (2009) Biochemical and Biophysical Research Communications. 387, 2, p. 399-404  Abstract
206.
Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
Shalgi R., Brosh R., Oren M., Pilpel Y. & Rotter V. (2009) AGING-US. 1, 9, p. 762-770  Abstract
205.
Pirngruber J., Shchebet A., Schreiber L. et al. (2009) EMBO Reports. 10, 8, p. 894-900  Abstract [All authors]
204.
Bar J., Feniger-Barish R., Lukashchuk N. et al. (2009) Oncogene. 28, 6, p. 933-936  Abstract [All authors]

2008

203.
Brosh R., Shalgi R., Liran A. et al. (2008) Molecular Systems Biology. 4,  Abstract [All authors]
202.
Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M. B. & Oren M. (2008) Molecular Cell. 32, 2, p. 180-189  Abstract
201.
Shema E., Tirosh I., Aylon Y. et al. (2008) GENES & DEVELOPMENT. 22, 19, p. 2664-2676  Abstract [All authors]
200.
Finkin S., Aylon Y., Anzi S., Oren M. & Shaulian E. (2008) Oncogene. 27, 32, p. 4411-4421  Abstract
199.
Bossi G., Marampon F., Maor-Aloni R., Zani B., Rotter V., Oren M., Strano S., Blandino G. & Sacchi A. (2008) Cell Cycle. 7, 12, p. 1870-1879  Abstract
198.
Minsky N., Shema E., Field Y., Schuster M., Segal E. & Oren M. (2008) Nature Cell Biology. 10, 4, p. 483-490  Abstract
197.
Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M. & Tanaka N. (2008) Proceedings of the National Academy of Sciences of the United States of America. 105, 12, p. 4838-4843  Abstract

2007

196.
Lantner F., Starlets D., Gore Y. et al. (2007) Blood. 110, 13, p. 4303-4311  Abstract [All authors]
195.
Tiny actors, great roles - MicroRNAs in p53's service
Raver-Shapira N. & Oren M. (2007) Cell Cycle. 6, 21, p. 2656-2661  Abstract
194.
Lu X., Ma O., Nguyen T., Joness S. N., Oren M. & Donehower L. A. (2007) Cancer Cell. 12, 4, p. 342-354  Abstract
193.
Reef S., Shifman O., Oren M. & Kimchi A. (2007) Oncogene. 26, 46, p. 6677-6683  Abstract
192.
Aylon Y. & Oren M. (2007) Cell. 130, 4, p. 597-600  Abstract
191.
Shalgi R., Lieber D., Oren M. & Pilpel Y. (2007) PLoS Computational Biology. 3, 7, p. 1291-1304  Abstract
190.
Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z. & Oren M. (2007) Molecular Cell. 26, 5, p. 731-743  Abstract
189.
Weisz L., Oren M. & Rotter V. (2007) Oncogene. 26, 15, p. 2202-2211  Abstract
188.
Oren M. & Bartek J. (2007) Cell. 128, 5, p. 826-828  Abstract
187.
Shmueli A. & Oren M. (2007) Molecular Cell. 25, 6, p. 794-796  Abstract
186.
Weisz L., Damalas A., Liontos M. et al. (2007) Cancer Research. 67, 6, p. 2396-2401  Abstract [All authors]

2006

185.
Stambolsky P., Weisz L., Shats I., Klein Y. A., Goldfinger N., Oren M. & Rotter V. (2006) Cell Death and Differentiation. 13, 12, p. 2140-2149  Abstract
184.
Oren M. (2006) Ejc Supplements. 4, 12, p. 76-76  Abstract
183.
Moskovits N., Kalinkovich A., Bar J. & Oren M. (2006) Cancer Research. 66, 22, p. 10671-10676  Abstract
182.
Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H. & Oren M. (2006) GENES & DEVELOPMENT. 20, 19, p. 2687-2700  Abstract
181.
Rentsch C. A., Germann M., Wetterwald A. et al. (2006) European Urology Supplements. 5, 14, p. 790-790  Abstract [All authors]
180.
Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M. & Kimchi A. (2006) Molecular Cell. 22, 4, p. 463-475  Abstract
179.
Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S., Oren M. & Livneh Z. (2006) Molecular Cell. 22, 3, p. 407-413  Abstract
178.
Kogan I., Goldfinger N., Milyavsky M. et al. (2006) Cancer Research. 66, 7, p. 3531-3540  Abstract [All authors]
177.
Margalit O., Amram H., Amariglio N. et al. (2006) Blood. 107, 4, p. 1599-1607  Abstract [All authors]
176.
Zalcenstein A., Weisz L., Stambolsky P., Bar J., Rotter V. & Oren M. (2006) Oncogene. 25, 3, p. 359-369  Abstract

2005

175.
Muller M., Schilling T., Sayan A. et al. (2005) Cell Death and Differentiation. 12, 12, p. 1564-1577  Abstract [All authors]
174.
Bar J., Lukaschuk N., Zalcenstein A., Wilder S., Seger R. & Oren M. (2005) Cell Death and Differentiation. 12, 12, p. 1578-1587  Abstract
173.
Shmueli A. & Oren M. (2005) Cell. 121, 7, p. 963-965  Abstract
172.
Gressner O., Schilling T., Lorenz K. et al. (2005) EMBO Journal. 24, 13, p. 2458-2471  Abstract [All authors]
171.
Oberst A., Rossi M., Salornoni P., Pandolfi P., Oren M., Melino G. & Bernassola F. (2005) Biochemical and Biophysical Research Communications. 331, 3, p. 707-712  Abstract
170.
Hershko T., Chaussepied M., Oren M. & Ginsberg D. (2005) Cell Death and Differentiation. 12, 4, p. 377-383  Abstract
169.
Wohlbold L., van der Kuip d. K. H., Moehring A., Granot G., Oren M., Vornlocher H. & Aulitzky W. (2005) Leukemia. 19, 2, p. 290-292  Abstract
168.
Damalas A., Weis L., Nordgard S. et al. (2005) Breast Cancer Research. 7, p. S53-S53  Abstract [All authors]

2004

167.
Minsky N. & Oren M. (2004) Molecular Cell. 16, 4, p. 631-639  Abstract
166.
Weisz L., Zalcenstein A., Stambolsky P., Cohen Y., Goldfinger N., Oren M. & Rotter V. (2004) Cancer Research. 64, 22, p. 8318-8327  Abstract
165.
Daniely Y., Liao G., Dixon D., Linnoila R., Lori A., Randell S., Oren M. & Jetten A. (2004) American Journal Of Physiology-Cell Physiology. 287, 1, p. C171-C181  Abstract
164.
Levina E., Oren M. & Ben-Ze'ev A. (2004) Oncogene. 23, 25, p. 4444-4453  Abstract
163.
Fiucci G., Beaucourt S., Duflaut D. et al. (2004) Proceedings of the National Academy of Sciences of the United States of America. 101, 10, p. 3510-3515  Abstract [All authors]
162.
Bar J., Cohen-Noyman E., Geiger B. & Oren M. (2004) Oncogene. 23, 12, p. 2128-2137  Abstract
161.
Wang X., Taplick J., Geva N. & Oren M. (2004) FEBS Letters. 561, 3-Jan, p. 195-201  Abstract
160.
Shmueli A. & Oren M. (2004) Molecular Cell. 13, 1, p. 4-5  Abstract

2003

159.
Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
158.
Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M. & Lavi S. (2003) Journal of Biological Chemistry. 278, 16, p. 14299-14305  Abstract
157.
Wang X., Zalcenstein A. & Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 468-476  Abstract
156.
Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 431-442  Abstract
155.
Passer B., Nancy-Portebois V., Amzallag N. et al. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2284-2289  Abstract [All authors]
154.
Michael D. Y. & Oren M. (2003) Seminars in Cancer Biology. 13, 1, p. 49-58  Abstract
153.
Nuclear factor-kappa B protects the liver against genotoxic stress and functions independently of p53
Lavon I., Pikarsky E., Gutkovich E., Goldberg I., Bar J., Oren M. & Ben-Neriah Y. (2003) Cancer Research. 63, 1, p. 25-30  Abstract

2002

152.
Blander G., Zalle N., Daniely Y., Taplick J., Gray M. & Oren M. (2002) Journal of Biological Chemistry. 277, 52, p. 50934-50940  Abstract
151.
OREN M., DAMALAS A., GOTTLIEB T. et al. (2002) Annals of the New York Academy of Sciences. 973, 1, p. 374-383  Abstract [All authors]
150.
Balass M., Kalef E., Maya R., Wilder S., Oren M. & Katchalski-Katzir E. (2002) Peptides. 23, 10, p. 1719-1725  Abstract
149.
Shtutman M., Zhurinsky J., Oren M., Levina E. & Ben-Ze'ev A. (2002) Cancer Research. 62, 20, p. 5947-5954  Abstract
148.
Courtois S., Verhaegh G., North S., Luciani M., Lassus P., Hibner U., Oren M. & Hainaut P. (2002) Oncogene. 21, 44, p. 6722-6728  Abstract
147.
Goldberg Z., Vogt Sionov S. R., Berger M., Zwang Y., Perets R., Van Etten E. R., Oren M., Taya Y. & Haupt Y. (2002) EMBO Journal. 21, 14, p. 3715-3727  Abstract
146.
Wang X., Michael D. Y., de Murcia M. G. & Oren M. (2002) Journal of Biological Chemistry. 277, 18, p. 15697-15702  Abstract
145.
Strano S., Fontemaggi G., Costanzo A. et al. (2002) Journal of Biological Chemistry. 277, 21, p. 18817-18826  Abstract [All authors]
144.
Folberg-Blum A., Sapir A., Shilo B. & Oren M. (2002) Oncogene. 21, 15, p. 2413-2417  Abstract
143.
Michael D. Y. & Oren M. (2002) Current opinion in genetics & development. 12, 1, p. 53-59  Abstract
142.
Gottlieb T., Leal J., Seger R., Taya Y. & Oren M. (2002) Oncogene. 21, 8, p. 1299-1303  Abstract

2001

141.
Susini L., Passer B., Amzallag-Elbaz N. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 26, p. 15067-15072  Abstract [All authors]
140.
Sadot E., Geiger B., Oren M. & Ben-Ze'ev A. (2001) Molecular and Cellular Biology. 21, 20, p. 6768-6781  Abstract
139.
Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
Goetz A., van der Kuip d. K. H., Maya R., Oren M. & Aulitzky W. (2001) Cancer Research. 61, 20, p. 7635-7641  Abstract
138.
Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A. & Oren M. (2001) EMBO Journal. 20, 17, p. 4912-4922  Abstract
137.
Maya R., Balass M., Kim S. et al. (2001) GENES & DEVELOPMENT. 15, 9, p. 1067-1077  Abstract [All authors]
136.
Strano S., Munarriz E., Rossi M. et al. (2001) Journal of Biological Chemistry. 276, 18, p. 15164-15173  Abstract [All authors]

2000

135.
The Warner syndrome protein contributes to induction of p53 by DNA damage
Blander G., Zalle N., Leal J., Bar-Or R., Yu C. & Oren M. (2000) FASEB Journal. 14, 14, p. 2138-2140  Abstract
134.
Reinstein E., Scheffner M., Oren M., Ciechanover A. & Schwartz A. (2000) Oncogene. 19, 51, p. 5944-5950  Abstract
133.
Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M. & McCormick F. (2000) Cell. 103, 2, p. 321-330  Abstract
132.
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Bar-Or R., Maya R., Segel L., Alon U., Levine A. & Oren M. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 21, p. 11250-11255  Abstract
131.
Strano S., Munarriz E., Rossi M. et al. (2000) Journal of Biological Chemistry. 275, 38, p. 29503-29512  Abstract [All authors]
130.
Maya R. & Oren M. (2000) Oncogene. 19, 28, p. 3213-3215  Abstract
129.
Amson R., Lassalle J., Halley H. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 10, p. 5346-5350  Abstract [All authors]
128.
de Rozieres R. S., Maya R., Oren M. & Lozano G. (2000) Oncogene. 19, 13, p. 1691-1697  Abstract

1999

127.
Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y. & Shkedy D. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 26, p. 14973-14977  Abstract
126.
Oren M. (1999) Journal of Biological Chemistry. 274, 51, p. 36031-36034  Abstract
125.
Blander G., Kipnis J., Leal J., Yu C., Schellenberg G. & Oren M. (1999) Journal of Biological Chemistry. 274, 41, p. 29463-29469  Abstract
124.
Roperch J., Lethrone F., Prieur S. et al. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 14, p. 8070-8073  Abstract [All authors]
123.
Interaction of c-Abl and p73 alpha and their collaboration to induce apoptosis
Agami R., Blandino G., Oren M. & Shaul Y. (1999) Nature. 399, 6738, p. 809-813  Abstract
122.
Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments
Oren M. & Vousden K. (1999) Scientist. 13, 12, p. 11-11  Abstract
121.
Damalas A., Ben-Ze'ev A., Simcha I., Shtutman N., Leal J., Zhurinsky J., Geiger B. & Oren M. (1999) EMBO Journal. 18, 11, p. 3054-3063  Abstract
120.
Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999) Oncogene. 18, 21, p. 3205-3212  Abstract
119.
MDM2 suppresses p73 function without promoting p73 degradation
Zeng X., Chen L., Jost C. et al. (1999) Molecular and Cellular Biology. 19, 5, p. 3257-3266  Abstract [All authors]
118.
Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999) EMBO Journal. 18, 7, p. 1805-1814  Abstract
117.
The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor
Elkeles A., Juven-Gershon T., Israeli D., Wilder S., Zalcenstein A. & Oren M. (1999) Molecular and Cellular Biology. 19, 4, p. 2594-2600  Abstract
116.
Sionov R., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M. & Haupt Y. (1999) Journal of Biological Chemistry. 274, 13, p. 8371-8374  Abstract
115.
Mdm2: The ups and downs
Juven-Gershon T. & Oren M. (1999) Molecular Medicine. 5, 2, p. 71-83  Abstract
114.
Blandino G., Levine A. & Oren M. (1999) Oncogene. 18, 2, p. 477-485  Abstract
113.
Oren M. & Rotter V. (1999) Cellular and Molecular Life Sciences. 55, 1, p. 9-11  Abstract

1998

112.
Muller M., Wilder S., Bannasch D. et al. (1998) Journal of Experimental Medicine. 188, 11, p. 2033-2045  Abstract [All authors]
111.
Hosokawa K., Aharoni D., Dantes A. et al. (1998) Endocrinology. 139, 11, p. 4688-4700  Abstract [All authors]
110.
Gottlieb T. & Oren M. (1998) Seminars in Cancer Biology. 8, 5, p. 359-368  Abstract
109.
Wang Y., Blandino G., Oren M. & Givol D. (1998) Oncogene. 17, 15, p. 1923-1930  Abstract
108.
The Mdm2 oncoprotein interacts with the cell fate regulator numb
Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998) Molecular and Cellular Biology. 18, 7, p. 3974-3982  Abstract
107.
Gottlieb E. & Oren M. (1998) EMBO Journal. 17, 13, p. 3587-3596  Abstract
106.
Roperch J., Alvaro V., Prieur S. et al. (1998) Nature Medicine. 4, 7, p. 835-838  Abstract [All authors]
105.
Yardley G., Zauberman A., Oren M. & Jackson P. (1998) FEBS Letters. 430, 3, p. 171-175  Abstract
104.
Oren M. (1998) Nature. 391, 6664, p. 233-234  Abstract
103.
Ori A., Zauberman A., Doitsh G., Paran N., Oren M. & Shaul Y. (1998) EMBO Journal. 17, 2, p. 544-553  Abstract

1997

102.
Shaulian E., Resnitzky D., Shifman O., Blandino G., Amsterdam A., Yayon A. & Oren M. (1997) Oncogene. 15, 22, p. 2717-2725  Abstract
101.
Zauberman A., Oren M. & Zipori D. (1997) Oncogene. 15, 14, p. 1705-1711  Abstract
99.
Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A. & Oren M. (1997) EMBO Journal. 16, 14, p. 4384-4392  Abstract
98.
Friedman S., Shaulian E., Littlewood T., Resnitzky D. & Oren M. (1997) Oncogene. 15, 1, p. 63-70  Abstract
97.
Haupt Y., Maya R., Kazaz A. & Oren M. (1997) Nature. 387, 6630, p. 296-299  Abstract
96.
Ruaro E., Collavin L., DelSal G., Haffner R., Oren M., Levine A. & Schneider C. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 9, p. 4675-4680  Abstract
95.
Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. & Oren M. (1997) EMBO Journal. 16, 6, p. 1381-1390  Abstract
94.
Hansen R. & Oren M. (1997) Current opinion in genetics & development. 7, 1, p. 46-51  Abstract

1996

93.
Oren M. & Prives C. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1288, 3, p. R13-R19  Abstract
92.
A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis
Friedlander P., Haupt Y., Prives C. & Oren M. (1996) Molecular and Cellular Biology. 16, 9, p. 4961-4971  Abstract
91.
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells
Eizenberg O., FaberElman A., Gottlieb E., Oren M., Rotter V. & Schwartz M. (1996) Molecular and Cellular Biology. 16, 9, p. 5178-5185  Abstract
90.
Nemani M., LinaresCruz G., BruzzoniGiovanelli H. et al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 17, p. 9039-9042  Abstract [All authors]
89.
Tanaka N., Ishihara M., Lamphier M. et al. (1996) Nature. 382, 6594, p. 816-818  Abstract [All authors]
88.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract [All authors]
87.
Gottlieb T. & Oren M. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1287, 3-Feb, p. 77-102  Abstract
86.
Bowman T., Symonds H., Gu L., Yin C., Oren M. & VanDyke T. (1996) GENES & DEVELOPMENT. 10, 7, p. 826-835  Abstract
85.
Cell type-specific inhibition of p53-mediated apoptosis by mdm2
Haupt Y., Barak Y. & Oren M. (1996) EMBO Journal. 15, 7, p. 1596-1606  Abstract
84.
Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion
Knippschild U., Oren M. & Deppert W. (1996) Oncogene. 12, 8, p. 1755-1765  Abstract
83.
Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells
Gottlieb E., Lindner S. & Oren M. (1996) Cell Growth & Differentiation. 7, 3, p. 301-310  Abstract
82.
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant
Rowan S., Ludwig R., Haupt Y., Bates S., Lu X., Oren M. & Vousden K. (1996) EMBO Journal. 15, 4, p. 827-838  Abstract
81.
p53-Mediated apoptosis - Regulatory and mechanistic aspects
Haupt Y., Rowan S., Shaulian E., Gottlieb E., YonishRouach E., Vousden K. & Oren M. (1996) Cancer Genes: Functional Aspects. 7, p. 83-101  Abstract

1995

80.
E2F-1/DP-1 INDUCES P53 AND OVERRIDES SURVIVAL FACTORS TO TRIGGER APOPTOSIS
HIEBERT S., PACKHAM G., STROM D., HAFFNER R., Oren M., ZAMBETTI G. & CLEVELAND J. (1995) Molecular and Cellular Biology. 15, 12, p. 6864-6874  Abstract
79.
Cancer: The translation of advances in basic science to human therapy. 22-27 July, 1995 - La fondation des Treilles, Tourtour, France - Discussion
Harlow E., Tlsty T., Courtneidge S. et al. (1995) Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences. 318, 11, p. 1173-1179  Abstract [All authors]
78.
LOSS OF P53 FUNCTION THROUGH PAX-MEDIATED TRANSCRIPTIONAL REPRESSION
STUART E., HAFFNER R., Oren M. & GRUSS P. (1995) EMBO Journal. 14, 22, p. 5638-5645  Abstract
77.
MALCOMSON R., Oren M., WYLLIE A. & HARRISON D. (1995) British Journal of Cancer. 72, 4, p. 952-957  Abstract
76.
HAUPT Y., ROWAN S., SHAULIAN E., VOUSDEN K. & Oren M. (1995) GENES & DEVELOPMENT. 9, 17, p. 2170-2183  Abstract
75.
Zauberman A., FLUSBERG D., HAUPT Y., Barak Y. & Oren M. (1995) Nucleic Acids Research. 23, 14, p. 2584-2592  Abstract
74.
IDENTIFICATION OF P53 TARGET GENES THROUGH IMMUNE SELECTION OF GENOMIC DNA - THE CYCLIN-G GENE CONTAINS 2 DISTINCT P53 BINDING-SITES
Zauberman A., LUPO A. & Oren M. (1995) Oncogene. 10, 12, p. 2361-2366  Abstract
73.
KERENTAL I., SUH B., Dantes A., LINDNER S., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 283-295  Abstract
72.
AHARONI D., Dantes A., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 271-282  Abstract
71.
P53-MEDIATED APOPTOSIS IN HELA-CELLS CAN BE OVERCOME BY EXCESS PRB
HAUPT Y., ROWAN S. & Oren M. (1995) Oncogene. 10, 8, p. 1563-1571  Abstract
70.
DIRECT INVOLVEMENT OF P53 IN PROGRAMMED CELL-DEATH OF OLIGODENDROCYTES
EIZENBERG O., FABERELMAN A., GOTTLIEB E., Oren M., Rotter V. & Schwartz M. (1995) EMBO Journal. 14, 6, p. 1136-1144  Abstract
69.
NON-SYNTENIC AMPLIFICATION OF MDM2 AND MYCN IN HUMAN NEUROBLASTOMA
CORVI R., SAVELYEVA L., BREIT S., WENZEL A., HANDGRETINGER R., BARAK J., Oren M., AMLER L. & SCHWAB M. (1995) Oncogene. 10, 6, p. 1081-1086  Abstract
68.
TRANSCRIPTIONAL REPRESSION BY THE C-TERMINAL DOMAIN OF P53
SHAULIAN E., HAVIV I., Shaul Y. & Oren M. (1995) Oncogene. 10, 4, p. 671-680  Abstract

1994

67.
Barak Y., GOTTLIEB E., JUVENGERSHON T. & Oren M. (1994) GENES & DEVELOPMENT. 8, 15, p. 1739-1749  Abstract
66.
RELATIONSHIP OF P53 TO THE CONTROL OF APOPTOTIC CELL-DEATH
Oren M. (1994) Seminars in Cancer Biology. 5, 3, p. 221-227  Abstract
65.
DEGRADATION OF THE TUMOR-SUPPRESSOR PROTEIN-P53 BY THE UBIQUITIN-MEDIATED PROTEOLYTIC SYSTEM REQUIRES A NOVEL SPECIES OF UBIQUITIN-CARRIER PROTEIN, E2
CIECHANOVER A., SHKEDY D., Oren M. & BERCOVICH B. (1994) Journal of Biological Chemistry. 269, 13, p. 9582-9589  Abstract
64.
DOWN-REGULATION OF WILD-TYPE P53 ACTIVITY INTERFERES WITH APOPTOSIS OF IL-3-DEPENDENT HEMATOPOIETIC-CELLS FOLLOWING IL-3 WITHDRAWAL
GOTTLIEB E., HAFFNER R., VONRUDEN T., WAGNER E. & Oren M. (1994) EMBO Journal. 13, 6, p. 1368-1374  Abstract
63.
TARGETS FOR TRANSCRIPTIONAL ACTIVATION BY WILD-TYPE P53 - ENDOGENOUS RETROVIRAL LTR, IMMUNOGLOBULIN-LIKE PROMOTER, AND AN INTERNAL PROMOTER OF THE MDM2 GENE
Barak Y., LUPO A., Zauberman A., JUVEN T., ALONIGRINSTEIN R., GOTTLIEB E., Rotter V. & Oren M. (1994) Cold Spring Harbor Symposia on Quantitative Biology. 59, p. 225-235  Abstract
62.
WILD-TYPE P(53) ACTIVITY CONTRIBUTES TO DEPENDENCE ON HEMATOPOIETIC SURVIVAL FACTORS
GOTTLIEB E., HAFFNER R., YONISHROUACH E., VONRUDEN T., WAGNER E. & Oren M. (1994) Apoptosis. 5, p. 31-45  Abstract

1993

61.
COMPLEMENTATION BY WILD-TYPE P53 OF INTERLEUKIN-6 EFFECTS ON M1 CELLS - INDUCTION OF CELL-CYCLE EXIT AND COOPERATIVITY WITH C-MYC SUPPRESSION
Levy N., YONISHROUACH E., Oren M. & Kimchi A. (1993) Molecular and Cellular Biology. 13, 12, p. 7942-7952  Abstract
60.
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
JUVEN T., Barak Y., Zauberman A., GEORGE D. & Oren M. (1993) Oncogene. 8, 12, p. 3411-3416  Abstract
59.
Telerman A., TUYNDER M., DUPRESSOIR T., ROBAYE B., SIGAUX F., SHAULIAN E., Oren M., ROMMELAERE J. & AMSON R. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 18, p. 8702-8706  Abstract
58.
SEQUENCE-SPECIFIC DNA-BINDING BY P53 - IDENTIFICATION OF TARGET SITES AND LACK OF BINDING TO P53MDM2 COMPLEXES
Zauberman A., Barak Y., RAGIMOV N., Levy N. & Oren M. (1993) EMBO Journal. 12, 7, p. 2799-2808  Abstract
57.
TIGHT DNA-BINDING AND OLIGOMERIZATION ARE DISPENSABLE FOR THE ABILITY OF P53 TO TRANSACTIVATE TARGET GENES AND SUPPRESS TRANSFORMATION
SHAULIAN E., Zauberman A., MILNER J., DAVIES E. & Oren M. (1993) EMBO Journal. 12, 7, p. 2789-2797  Abstract
56.
ALONI, YOSEF - (1936-1993) - OBITUARY
Oren M. (1993) Oncogene. 8, 6, p. 1405-1405  Abstract
55.
WILD-TYPE BUT NOT MUTANT-P53 CAN REPRESS TRANSCRIPTION INITIATION INVITRO BY INTERFERING WITH THE BINDING OF BASAL TRANSCRIPTION FACTORS TO THE TATA MOTIF
RAGIMOV N., KRAUSKOPF A., NAVOT N., Rotter V., Oren M. & ALONI Y. (1993) Oncogene. 8, 5, p. 1183-1193  Abstract
54.
P53-MEDIATED CELL-DEATH - RELATIONSHIP TO CELL-CYCLE CONTROL
YONISHROUACH E., GRUNWALD D., Wilder S., Kimchi A., MAY E., LAWRENCE J., MAY P. & Oren M. (1993) Molecular and Cellular Biology. 13, 3, p. 1415-1423  Abstract
53.
MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
Barak Y., JUVEN T., HAFFNER R. & Oren M. (1993) EMBO Journal. 12, 2, p. 461-468  Abstract

1992

52.
IDENTIFICATION OF A MINIMAL TRANSFORMING DOMAIN OF P53 - NEGATIVE DOMINANCE THROUGH ABROGATION OF SEQUENCE-SPECIFIC DNA-BINDING
SHAULIAN E., Zauberman A., GINSBERG D. & Oren M. (1992) Molecular and Cellular Biology. 12, 12, p. 5581-5592  Abstract
51.
THE GENE FOR THE RAT HEAT-SHOCK COGNATE, HSC70, CAN SUPPRESS ONCOGENE-MEDIATED TRANSFORMATION
YEHIELY F. & Oren M. (1992) Cell Growth & Differentiation. 3, 11, p. 803-809  Abstract
50.
P53 - THE ULTIMATE TUMOR SUPPRESSOR GENE
Oren M. (1992) FASEB Journal. 6, 13, p. 3169-3176  Abstract
49.
Oren M. (1992) Cancer and Metastasis Reviews. 11, 2, p. 141-148  Abstract
48.
ENHANCED BINDING OF A 95-KDA PROTEIN TO P53 IN CELLS UNDERGOING P53-MEDIATED GROWTH ARREST
Barak Y. & Oren M. (1992) EMBO Journal. 11, 6, p. 2115-2121  Abstract

1991

47.
EIZENBERG O. & Oren M. (1991) Biochimica Et Biophysica Acta. 1129, 1, p. 34-42  Abstract
46.
GINSBERG D., MECHTA F., Yaniv M. & Oren M. (1991) Proceedings of the National Academy of Sciences of the United States of America. 88, 22, p. 9979-9983  Abstract
45.
FREQUENT P53 MUTATIONS IN CHEMICALLY-INDUCED MURINE FIBROSARCOMA
Halevy O., RODEL J., Peled A. & Oren M. (1991) Oncogene. 6, 9, p. 1593-1600  Abstract
44.
Michael D., YEHIELY F., GOTTLIEB E. & Oren M. (1991) Journal of Virology. 65, 8, p. 4160-4168  Abstract
43.
YONISHROUACH E., RESNITZKY D., Lotem J., Sachs L., Kimchi A. & Oren M. (1991) Nature. 352, 6333, p. 345-347  Abstract
42.
TRANSFECTED MOUSE C-JUN CAN INHIBIT TRANSFORMATION OF PRIMARY RAT EMBRYO FIBROBLASTS
GINSBERG D., HIRAI S., PINHASIKIMHI O., Yaniv M. & Oren M. (1991) Oncogene. 6, 4, p. 669-672  Abstract
41.
MICHALOVITZ D., Halevy O. & Oren M. (1991) Journal of Cellular Biochemistry. 45, 1, p. 22-29  Abstract
40.
GINSBERG D., Michael D. & Oren M. (1991) Molecular and Cellular Biology. 11, 1, p. 582-585  Abstract

1990

39.
Halevy O., MICHALOVITZ D. & Oren M. (1990) Science. 250, 4977, p. 113-116  Abstract
38.
PROTEIN-BINDING ELEMENTS IN THE PROMOTER REGION OF THE MOUSE P53 GENE
GINSBERG D., Oren M., Yaniv M. & PIETTE J. (1990) Oncogene. 5, 9, p. 1285-1290  Abstract
36.
Eliyahu D., Michael D. Y., Eliyahu S., Pinchas-Kimhi O. & Oren M. (1990) Oncogenes in Cancer Diagnosis. Bartram CR., Munk K. & Schwab M.(eds.). p. 125-134  Abstract

1989

35.
Eliyahu D., MICHALOVITZ D., ELIYAHU S., PINHASIKIMHI O. & Oren M. (1989) Proceedings of the National Academy of Sciences of the United States of America. 86, 22, p. 8763-8767  Abstract
34.
STABILIZATION OF THE P53 TRANSFORMATION-RELATED PROTEIN IN MOUSE FIBRO-SARCOMA CELL-LINES - EFFECTS OF PROTEIN-SEQUENCE AND INTRACELLULAR ENVIRONMENT
Halevy O., HALL A. & Oren M. (1989) Molecular and Cellular Biology. 9, 8, p. 3385-3392  Abstract
33.
INTERACTIONS BETWEEN SV40 AND CELLULAR ONCOGENES IN THE TRANSFORMATION OF PRIMARY RAT-CELLS
MICHALOVITZ D., Amsterdam A. & Oren M. (1989) Current Topics in Microbiology and Immunology. 144, p. 63-75  Abstract

1988

32.
OLIGOMERIZATION OF ONCOPROTEIN-P53
KRAISS S., QUAISER A., Oren M. & MONTENARH M. (1988) Journal of Virology. 62, 12, p. 4737-4744  Abstract
31.
Amsterdam A., Zauberman A., Meir G., PINHASIKIMHI O., SUH B. & Oren M. (1988) Proceedings of the National Academy of Sciences of the United States of America. 85, 20, p. 7582-7586  Abstract
30.
METH-A FIBRO-SARCOMA CELLS EXPRESS 2 TRANSFORMING MUTANT P53 SPECIES
Eliyahu D., Goldfinger N., PINHASIKIMHI O., SHAULSKY G., SKURNIK Y., ARAI N., Rotter V. & Oren M. (1988) Oncogene. 3, 3, p. 313-321  Abstract
29.
ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE
FINLAY C., HINDS P., TAN T., Eliyahu D., Oren M. & LEVINE A. (1988) Molecular and Cellular Biology. 8, 2, p. 531-539  Abstract
28.
Complex Formation Between the p53 Cellular Tumor Antigen and Nuclear Heat Shock Proteins
Michalovitz (Michael) D., Pinhasi-Kimchi O., Eliyahu D., Ben-Ze'ev A. & Oren M. (1988) Cellular and Molecular Biology of Tumors and Potential Application. Liss A. R., Minna J. & Kuehl WM.(eds.). Vol. 56. p. 247-259 (UCLA Symposia on Molecular & Cellular Biology).  Abstract

1987

27.
MICHALOVITZ D., FISCHERFANTUZZI L., VESCO C., PIPAS J. & Oren M. (1987) Journal of Virology. 61, 8, p. 2648-2654  Abstract